vs
Side-by-side financial comparison of ENTEGRIS INC (ENTG) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
ENTEGRIS INC is the larger business by last-quarter revenue ($823.9M vs $608.1M, roughly 1.4× Hims & Hers Health, Inc.). On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (3.8% vs -3.1%). ENTEGRIS INC produced more free cash flow last quarter ($134.0M vs $53.0M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (38.8% CAGR vs 3.4%).
Entegris, Inc. is a supplier of materials for the semiconductor and other high-tech industries. Entegris has approximately 8,000 employees throughout its global operations. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, and Taiwan. The company’s corporate headquarters are in Billerica, Massachusetts.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ENTG vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $823.9M | $608.1M |
| Net Profit | $49.4M | — |
| Gross Margin | 43.8% | 65.2% |
| Operating Margin | 12.7% | 21.9% |
| Net Margin | 6.0% | — |
| Revenue YoY | -3.1% | 3.8% |
| Net Profit YoY | -51.7% | — |
| EPS (diluted) | $0.33 | $-0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $608.1M | ||
| Q4 25 | $823.9M | $617.8M | ||
| Q3 25 | $807.1M | $599.0M | ||
| Q2 25 | $792.4M | $544.8M | ||
| Q1 25 | $773.2M | $586.0M | ||
| Q4 24 | $849.8M | $481.1M | ||
| Q3 24 | $807.7M | $401.6M | ||
| Q2 24 | $812.7M | $315.6M |
| Q1 26 | — | — | ||
| Q4 25 | $49.4M | $20.6M | ||
| Q3 25 | $70.5M | $15.8M | ||
| Q2 25 | $52.8M | $42.5M | ||
| Q1 25 | $62.9M | $49.5M | ||
| Q4 24 | $102.2M | $26.0M | ||
| Q3 24 | $77.6M | $75.6M | ||
| Q2 24 | $67.7M | $13.3M |
| Q1 26 | — | 65.2% | ||
| Q4 25 | 43.8% | 71.9% | ||
| Q3 25 | 43.5% | 73.8% | ||
| Q2 25 | 44.4% | 76.4% | ||
| Q1 25 | 46.1% | 73.5% | ||
| Q4 24 | 45.6% | 76.8% | ||
| Q3 24 | 46.0% | 79.2% | ||
| Q2 24 | 46.2% | 81.3% |
| Q1 26 | — | 21.9% | ||
| Q4 25 | 12.7% | 1.5% | ||
| Q3 25 | 15.2% | 2.0% | ||
| Q2 25 | 13.4% | 4.9% | ||
| Q1 25 | 15.8% | 9.9% | ||
| Q4 24 | 17.6% | 3.9% | ||
| Q3 24 | 16.9% | 5.6% | ||
| Q2 24 | 16.0% | 3.5% |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 3.3% | ||
| Q3 25 | 8.7% | 2.6% | ||
| Q2 25 | 6.7% | 7.8% | ||
| Q1 25 | 8.1% | 8.4% | ||
| Q4 24 | 12.0% | 5.4% | ||
| Q3 24 | 9.6% | 18.8% | ||
| Q2 24 | 8.3% | 4.2% |
| Q1 26 | — | $-0.40 | ||
| Q4 25 | $0.33 | $0.08 | ||
| Q3 25 | $0.46 | $0.06 | ||
| Q2 25 | $0.35 | $0.17 | ||
| Q1 25 | $0.41 | $0.20 | ||
| Q4 24 | $0.67 | $0.10 | ||
| Q3 24 | $0.51 | $0.32 | ||
| Q2 24 | $0.45 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $360.4M | $222.3M |
| Total DebtLower is stronger | $3.7B | — |
| Stockholders' EquityBook value | $4.0B | $446.2M |
| Total Assets | $8.4B | $2.3B |
| Debt / EquityLower = less leverage | 0.94× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $222.3M | ||
| Q4 25 | $360.4M | $228.6M | ||
| Q3 25 | $399.8M | $345.8M | ||
| Q2 25 | $376.8M | $1.1B | ||
| Q1 25 | $340.9M | $273.7M | ||
| Q4 24 | $329.2M | $220.6M | ||
| Q3 24 | $432.1M | $165.5M | ||
| Q2 24 | $320.0M | $129.3M |
| Q1 26 | — | — | ||
| Q4 25 | $3.7B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $4.1B | — | ||
| Q2 24 | $4.1B | — |
| Q1 26 | — | $446.2M | ||
| Q4 25 | $4.0B | $540.9M | ||
| Q3 25 | $3.9B | $581.0M | ||
| Q2 25 | $3.8B | $562.7M | ||
| Q1 25 | $3.7B | $549.3M | ||
| Q4 24 | $3.7B | $476.7M | ||
| Q3 24 | $3.6B | $440.1M | ||
| Q2 24 | $3.5B | $362.0M |
| Q1 26 | — | $2.3B | ||
| Q4 25 | $8.4B | $2.2B | ||
| Q3 25 | $8.4B | $2.2B | ||
| Q2 25 | $8.4B | $1.9B | ||
| Q1 25 | $8.4B | $891.7M | ||
| Q4 24 | $8.4B | $707.5M | ||
| Q3 24 | $8.5B | $602.3M | ||
| Q2 24 | $8.3B | $480.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.94× | — | ||
| Q3 25 | 0.99× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.06× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $192.0M | $89.4M |
| Free Cash FlowOCF − Capex | $134.0M | $53.0M |
| FCF MarginFCF / Revenue | 16.3% | 8.7% |
| Capex IntensityCapex / Revenue | 7.0% | — |
| Cash ConversionOCF / Net Profit | 3.89× | — |
| TTM Free Cash FlowTrailing 4 quarters | $396.2M | $60.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $89.4M | ||
| Q4 25 | $192.0M | $61.3M | ||
| Q3 25 | $249.5M | $148.7M | ||
| Q2 25 | $113.5M | $-19.1M | ||
| Q1 25 | $140.4M | $109.1M | ||
| Q4 24 | $176.1M | $86.4M | ||
| Q3 24 | $197.2M | $85.3M | ||
| Q2 24 | $111.2M | $53.6M |
| Q1 26 | — | $53.0M | ||
| Q4 25 | $134.0M | $-2.5M | ||
| Q3 25 | $182.8M | $79.3M | ||
| Q2 25 | $47.0M | $-69.5M | ||
| Q1 25 | $32.4M | $50.1M | ||
| Q4 24 | $68.6M | $59.5M | ||
| Q3 24 | $115.0M | $79.4M | ||
| Q2 24 | $51.9M | $47.6M |
| Q1 26 | — | 8.7% | ||
| Q4 25 | 16.3% | -0.4% | ||
| Q3 25 | 22.6% | 13.2% | ||
| Q2 25 | 5.9% | -12.8% | ||
| Q1 25 | 4.2% | 8.5% | ||
| Q4 24 | 8.1% | 12.4% | ||
| Q3 24 | 14.2% | 19.8% | ||
| Q2 24 | 6.4% | 15.1% |
| Q1 26 | — | — | ||
| Q4 25 | 7.0% | 10.3% | ||
| Q3 25 | 8.3% | 11.6% | ||
| Q2 25 | 8.4% | 9.3% | ||
| Q1 25 | 14.0% | 10.1% | ||
| Q4 24 | 12.7% | 5.6% | ||
| Q3 24 | 10.2% | 1.5% | ||
| Q2 24 | 7.3% | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 3.89× | 2.98× | ||
| Q3 25 | 3.54× | 9.43× | ||
| Q2 25 | 2.15× | -0.45× | ||
| Q1 25 | 2.23× | 2.20× | ||
| Q4 24 | 1.72× | 3.32× | ||
| Q3 24 | 2.54× | 1.13× | ||
| Q2 24 | 1.64× | 4.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
HIMS
| United States Revenue | $529.9M | 87% |
| Rest of the World Revenue | $78.2M | 13% |
